Chemical formula: C₁₃H₁₆N₃NaO₄S Molecular mass: 311.36 g/mol PubChem compound: 522325
Metamizole sodium is a pyrazolone derivative with analgesic, antipyretic and slight antiinflammatory and spasmolytic properties. It has the most potent analgesic effect of all the pyrazolone derivatives. As with other analgesics, its mechanism of action has not been elucidated in detail. It includes inhibition of prostaglandin synthesis (PGE1 and PGE2) and reversible inhibition of platelet aggregation. It inhibits cyclo-oxygenase and influences the effect of arachidonic acid.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
N02BB02 | Metamizole sodium | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BB Pyrazolones |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
METAMIZOLE SODIUM Oral drops, solution | European Medicines Agency (EU) | MPI, EU: SmPC |
Metamizole sodium is an active ingredient of these brands:
Albania (AL)Brazil (BR)
Finland (FI)
Germany (DE)Mexico (MX)
Poland (PL)
Romania (RO)South Africa (ZA)
Spain (ES)
Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.